Vector-borne Diseases

These are the infections transmitted by the mosquitoes, bugs, ticks, flies etc. One major factor that influences their growth is climate. These accounts for more than 17 percent of all infectious diseases. Dengue and Malaria are the major ones causing more number of deaths. Maintaining clean and proper environmental factors and social factors will helps in disease control and elimination

Global Anti-Malarial Drugs market reached USD 742.5 Million in 2016 at a CAGR of 3.2% across the world. The market is predicted as USD 1,049.5 Million by 2027. Middle East & Africa accounts for a share of 51.0% by 2027 and Asia Pacific of 30.2% by 2027. Moreover, the market is anticipated to account $317.0 Million by 2027 from $222.8 Million in 2016. China & India is the major contributor to the growth of Asia Pacific Anti-Malarial Drugs market. 

Sub-Tracks

  • Malaria
  • Dengue fever and Chikungunya
  • Leishmaniasis and Yellow fever
  • Zika and Lymphatic filariasis
  • Schistosomiasis
  • Japanese encephalitis and Onchocerciasis

Market Analysis: The global market for vector-borne diseases is poised for substantial growth, driven by a confluence of public health challenges and technological advancements. The vector control market, a major component, was valued at approximately $22.22 billion in 2025 and is projected to reach $30.14 billion by 2030, with a CAGR of 6.24%. This expansion is fueled by the rising incidence of diseases like dengue and malaria, which are spreading to new geographic regions due to climate change and rapid urbanization. While North America currently holds the largest market share, the Asia-Pacific region is anticipated to be the fastest-growing market, with a forecasted CAGR of 7.28% between 2024 and 2031, due to its high population density and significant disease burden. The market's evolution is also being shaped by a shift toward more sustainable and technologically advanced solutions. This includes a growing demand for biological control methods, AI-driven surveillance systems, and a move away from traditional chemical-based insecticides as vectors develop resistance.

For More Details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/vector-borne-diseases

+1 (506) 909-0537